Perioperative Hypotension and Shock

Perioperative hypotension and shock refer to a spectrum of acute, life-threatening cardiovascular derangements occurring during the perioperative period, encompassing the preanesthetic, intraoperative, and immediate postoperative phases. Hypotension is defined as a mean arterial pressure (MAP) of less than 60 mmHg in dogs and less than 50 mmHg in cats, or a systolic arterial pressure (SAP) of less than 90 mmHg in dogs and less than 80 mmHg in cats, resulting in inadequate tissue perfusion and oxygen delivery. Shock is a more severe state of circulatory failure characterized by global tissue hypoxia, cellular energy failure, and metabolic derangements, which if untreated, progresses to multiple organ dysfunction syndrome (MODS) and death. In the surgical context, perioperative hypotension and shock can be classified into hypovolemic, distributive (septic, anaphylactic, neurogenic), cardiogenic, and obstructive types, each with distinct pathophysiological mechanisms and therapeutic implications. The condition is a critical anesthetic complication that demands immediate recognition and aggressive intervention to prevent irreversible organ damage and mortality.

The etiology of perioperative hypotension and shock is multifactorial, involving patient-related, procedure-related, and anesthesia-related factors. Hypovolemic shock results from absolute or relative intravascular volume depletion due to preoperative dehydration, hemorrhage (traumatic, surgical, or coagulopathic), or third-space fluid losses (e.g., peritonitis, pleuritis, burns). Distributive shock arises from systemic vasodilation and maldistribution of blood flow, commonly due to sepsis (endotoxemia), systemic inflammatory response syndrome (SIRS), anaphylaxis (drug reactions, blood transfusions), or neurogenic causes (spinal cord injury, high neuraxial blockade). Cardiogenic shock occurs when the heart fails to maintain adequate cardiac output, resulting from myocardial depression (anesthetic agents, hypoxia, acidosis), arrhythmias (ventricular tachycardia, bradyarrhythmias), valvular dysfunction, or myocardial ischemia. Obstructive shock is caused by mechanical obstruction to blood flow, such as pericardial tamponade, tension pneumothorax, pulmonary thromboembolism, or severe dynamic airway obstruction. Anesthesia-related factors include dose-dependent cardiovascular depression from inhalant anesthetics (halothane, isoflurane, sevoflurane, desflurane), which cause dose-dependent decreases in systemic vascular resistance (SVR) and myocardial contractility; vasodilatory effects of propofol and acepromazine; bradycardia and decreased contractility from opioids (e.g., fentanyl, hydromorphone); and sympathetic blockade from epidural or spinal anesthesia. Additionally, positive-pressure ventilation reduces venous return and cardiac output, especially in hypovolemic patients. Surgical factors include blood loss, manipulation of major vessels, tumor manipulation (release of vasoactive mediators), and surgical stress responses.

Perioperative hypotension and shock are common complications in veterinary anesthesia, with reported incidence rates varying from 5% to 40% in dogs and cats undergoing general anesthesia. The incidence is higher in emergency surgeries, trauma cases, and patients with pre-existing cardiovascular disease, sepsis, or hypovolemia. Hypotension is more frequently observed in dogs than cats, possibly due to differences in cardiovascular reserve and anesthetic sensitivity. Brachycephalic breeds (e.g., Bulldogs, Pugs) are at increased risk due to underlying respiratory compromise and potential for hypoxemia and hypercapnia, which can exacerbate cardiovascular depression. Geriatric patients have reduced cardiovascular compliance and are more susceptible to anesthetic-induced hypotension. Conversely, pediatric patients may have limited compensatory mechanisms. Certain breeds, such as Greyhounds and other sighthounds, have unique physiological characteristics (e.g., high hematocrit, low body fat) that may influence drug distribution and cardiovascular responses. Cats are particularly sensitive to the hypotensive effects of alpha-2 agonists (e.g., dexmedetomidine) and are prone to bradycardia. The risk of perioperative shock is significantly elevated in patients with American Society of Anesthesiologists (ASA) physical status III-V, undergoing emergency procedures, or with pre-existing organ dysfunction (renal, hepatic, cardiac).

The pathophysiology of perioperative hypotension and shock involves a complex interplay of cellular, vascular, and systemic mechanisms. In hypovolemic shock, decreased intravascular volume leads to reduced venous return, decreased preload, and subsequent fall in stroke volume and cardiac output. Compensatory mechanisms include baroreceptor-mediated sympathetic activation, resulting in tachycardia, peripheral vasoconstriction, and increased myocardial contractility. However, under anesthesia, these reflexes are blunted, and the compensatory response is inadequate. As shock progresses, tissue hypoperfusion leads to cellular hypoxia, depletion of ATP, and shift to anaerobic metabolism, producing lactic acidosis. Cellular membrane dysfunction causes sodium and water influx, cellular swelling, and release of lysosomal enzymes. In distributive shock, systemic vasodilation causes relative hypovolemia and maldistribution of blood flow, leading to tissue hypoperfusion despite normal or increased cardiac output. Endotoxins and inflammatory cytokines (TNF-alpha, IL-1, IL-6) induce endothelial damage, increased capillary permeability, and activation of the coagulation cascade, resulting in microvascular thrombosis and further tissue ischemia. Cardiogenic shock results from impaired myocardial contractility, leading to reduced cardiac output and compensatory vasoconstriction, which increases afterload and myocardial oxygen demand, worsening ischemia. Obstructive shock impedes cardiac filling or outflow, causing decreased cardiac output and compensatory tachycardia. Regardless of the etiology, prolonged shock leads to irreversible cellular damage, activation of the systemic inflammatory response, and multiple organ dysfunction, including acute kidney injury, acute respiratory distress syndrome (ARDS), hepatic failure, and disseminated intravascular coagulation (DIC).

Predisposing factors for perioperative hypotension and shock include patient-related, procedure-related, and anesthesia-related factors. Patient-related factors include: (1) Hypovolemia due to dehydration, hemorrhage, vomiting, diarrhea, or third-space losses; (2) Pre-existing cardiovascular disease such as dilated cardiomyopathy, valvular disease, or arrhythmias; (3) Sepsis or systemic inflammatory response syndrome; (4) Endocrine disorders like hypoadrenocorticism (Addison's disease) or hypothyroidism; (5) Hepatic or renal insufficiency affecting drug metabolism and fluid balance; (6) Age extremes (neonates, geriatrics) with limited cardiovascular reserve; (7) Obesity, which increases anesthetic risk and cardiovascular workload; (8) Breed predispositions (e.g., brachycephalic syndrome, sighthounds with altered drug responses); (9) Trauma with occult hemorrhage or spinal cord injury; (10) Pregnancy, as the gravid uterus can compress the caudal vena cava in dorsal recumbency. Procedure-related factors include: (1) Major surgical procedures with significant blood loss or fluid shifts (e.g., splenectomy, liver lobectomy, fracture repair); (2) Prolonged anesthesia duration; (3) Surgical manipulation of thoracic or abdominal cavities causing vagal stimulation; (4) Use of tourniquets or positioning that impairs venous return; (5) Laparoscopy with pneumoperitoneum, which increases intra-abdominal pressure and reduces venous return. Anesthesia-related factors include: (1) Use of vasodilatory drugs (acepromazine, propofol, inhalant anesthetics); (2) High doses of opioids causing bradycardia; (3) Alpha-2 agonists (dexmedetomidine) causing vasoconstriction and bradycardia; (4) Epidural or spinal anesthesia causing sympathetic blockade; (5) Inadequate fluid resuscitation prior to anesthesia; (6) Hypoxemia or hypercapnia due to inadequate ventilation; (7) Hypothermia, which impairs cardiovascular function and drug metabolism.

Clinical signs of perioperative hypotension and shock vary depending on the severity and underlying cause. Early signs may be subtle and include tachycardia, weak or thready pulses, prolonged capillary refill time (CRT > 2 seconds), pale or cyanotic mucous membranes, and cool extremities. Hypotension may be detected via direct or indirect blood pressure monitoring, with MAP < 60 mmHg (dogs) or < 50 mmHg (cats). As shock progresses, mentation changes occur, ranging from depression to obtundation or coma. Tachypnea or respiratory distress may be present due to metabolic acidosis or pulmonary edema. Urine output decreases (< 0.5 mL/kg/hr) due to renal hypoperfusion. In hypovolemic shock, signs of dehydration (skin tenting, dry mucous membranes) may be evident. In distributive shock, hyperemia or injected mucous membranes may be seen initially, followed by pallor. In cardiogenic shock, signs of congestive heart failure (pulmonary crackles, jugular distension, arrhythmias) may be present. In obstructive shock, muffled heart sounds (pericardial effusion), absent lung sounds (pneumothorax), or distended jugular veins (cranial vena cava syndrome) may be noted. Intraoperative monitoring may reveal electrocardiographic changes (arrhythmias, ST segment changes), decreased end-tidal carbon dioxide (ETCO2) due to reduced cardiac output, and decreased pulse oximetry (SpO2) readings. Postoperative patients may exhibit prolonged recovery, weakness, or collapse.

Differential diagnoses for perioperative hypotension and shock include: (1) Hypovolemic shock due to hemorrhage (surgical, traumatic, coagulopathy) or dehydration; (2) Distributive shock due to sepsis (bacterial translocation, endotoxemia), anaphylaxis (drug reactions, blood transfusion reactions), or neurogenic shock (spinal cord injury, high epidural block); (3) Cardiogenic shock due to myocardial depression (anesthetic agents, hypoxia, acidosis), arrhythmias (ventricular tachycardia, bradyarrhythmias), or valvular disease; (4) Obstructive shock due to pericardial tamponade, tension pneumothorax, pulmonary thromboembolism, or dynamic airway obstruction; (5) Hypoadrenocorticism (Addisonian crisis) causing hypotension and electrolyte imbalances; (6) Hypoglycemia causing altered mentation and cardiovascular depression; (7) Hypothermia causing bradycardia and decreased cardiac output; (8) Drug-induced vasodilation or myocardial depression (e.g., acepromazine, propofol, inhalants); (9) Acid-base and electrolyte disturbances (e.g., hyperkalemia, hypocalcemia) affecting cardiac function; (10) Pulmonary embolism (air, fat, thrombus) causing acute right heart failure and obstructive shock. Each differential must be systematically evaluated based on history, physical examination, monitoring data (blood pressure, ECG, ETCO2, SpO2), and point-of-care ultrasound (POCUS) to guide appropriate therapy.

The diagnostic algorithm for perioperative hypotension and shock begins with immediate recognition of abnormal vital signs and blood pressure. Step 1: Confirm hypotension with oscillometric or Doppler blood pressure measurement; if MAP < 60 mmHg (dog) or < 50 mmHg (cat), initiate emergency assessment. Step 2: Perform a rapid physical examination focusing on mucous membrane color, CRT, pulse quality, heart rate and rhythm, lung auscultation, and abdominal palpation. Step 3: Assess perfusion parameters: lactate concentration (elevated > 2 mmol/L indicates tissue hypoxia), central venous oxygen saturation (ScvO2 < 70% suggests inadequate oxygen delivery), and urine output. Step 4: Obtain an electrocardiogram (ECG) to identify arrhythmias (bradycardia, tachycardia, ventricular arrhythmias). Step 5: Perform point-of-care ultrasound (POCUS) of the thorax and abdomen to evaluate for pericardial effusion, pleural effusion, pneumothorax, abdominal free fluid (hemorrhage), and cardiac function (fractional shortening, chamber dimensions). Step 6: If hemorrhage is suspected, assess coagulation status (PT, aPTT, platelet count, viscoelastic testing) and consider blood typing and crossmatch for transfusion. Step 7: In cases of suspected sepsis, obtain blood cultures, measure lactate, and assess for source of infection (e.g., septic abdomen). Step 8: Evaluate acid-base status via blood gas analysis (pH, base deficit, lactate) to guide fluid and bicarbonate therapy. Step 9: Monitor trends in blood pressure, heart rate, respiratory rate, ETCO2, and SpO2 to assess response to treatment. Step 10: In refractory hypotension, consider advanced hemodynamic monitoring such as central venous pressure (CVP) or arterial catheterization for direct blood pressure measurement and blood sampling. The diagnostic approach is dynamic and must be repeated frequently to guide therapy.

Laboratory findings in perioperative hypotension and shock reflect the underlying etiology and severity of tissue hypoperfusion. Hematology may reveal hemoconcentration (increased PCV) in hypovolemic shock due to dehydration, or anemia (decreased PCV) in hemorrhagic shock. Leukocytosis or leukopenia may be present in sepsis. Thrombocytopenia may indicate DIC or hemorrhage. Biochemistry may show elevated lactate (> 2 mmol/L) due to anaerobic metabolism, elevated blood urea nitrogen (BUN) and creatinine due to renal hypoperfusion, elevated liver enzymes (ALT, AST) due to hepatic ischemia, and hyperglycemia or hypoglycemia due to stress or hepatic dysfunction. Electrolyte abnormalities include hyperkalemia (tissue breakdown, acidosis), hyponatremia (hypoadrenocorticism), and hypocalcemia (critical illness). Blood gas analysis reveals metabolic acidosis (decreased pH, decreased bicarbonate, increased base deficit) in shock, with respiratory compensation (decreased PaCO2) or respiratory acidosis (increased PaCO2) if ventilation is impaired. Coagulation panel (PT, aPTT, fibrinogen, D-dimer) may be prolonged in DIC or coagulopathy. In sepsis, blood cultures may be positive, and inflammatory biomarkers such as C-reactive protein (CRP) and serum amyloid A (SAA) are elevated. Urinalysis may show casts, proteinuria, or decreased urine specific gravity due to acute kidney injury. Central venous oxygen saturation (ScvO2) < 70% indicates inadequate oxygen delivery. These findings guide fluid therapy, vasopressor support, and specific treatments.

Imaging plays a crucial role in identifying the underlying cause of perioperative hypotension and shock. Thoracic radiography may reveal pulmonary edema (cardiogenic shock), pneumothorax (obstructive shock), pleural effusion (hemorrhage, chylothorax), or cardiomegaly (pericardial effusion, cardiomyopathy). Abdominal radiography may show free abdominal fluid (hemorrhage, peritonitis), organomegaly (splenic mass), or gastrointestinal obstruction. Ultrasonography (POCUS) is invaluable in the emergency setting: focused cardiac ultrasound (FOCUS) can assess cardiac function (fractional shortening, ejection fraction), pericardial effusion, and right heart strain (pulmonary thromboembolism). Abdominal ultrasound can detect free fluid (FAST scan), organ lesions (splenic mass, hepatic mass), and assess the urinary bladder. Thoracic ultrasound can identify pleural effusion, lung consolidation, or pneumothorax. Computed tomography (CT) may be indicated in stable patients to evaluate for pulmonary thromboembolism, aortic dissection, or intra-abdominal hemorrhage. In trauma cases, CT can identify occult hemorrhage or spinal injury. Angiography or CT angiography can diagnose pulmonary embolism or vascular anomalies. Fluoroscopy may be used during interventional procedures. Imaging findings guide surgical intervention (e.g., splenectomy for hemangiosarcoma, thoracocentesis for pneumothorax) and medical management.

Cytology and histopathology are essential in diagnosing the underlying cause of shock when a mass or effusion is present. Abdominocentesis or thoracocentesis fluid analysis: (1) Hemorrhagic effusion (PCV > 10%) suggests hemangiosarcoma, trauma, or coagulopathy; cytology may show neoplastic cells (e.g., hemangiosarcoma) or inflammatory cells. (2) Septic effusion (degenerate neutrophils with intracellular bacteria) confirms peritonitis or pyothorax. (3) Chylous effusion (triglyceride-rich) may indicate thoracic duct rupture or neoplasia. (4) Transudate or modified transudate may be seen in heart failure or neoplasia. Fine-needle aspiration of masses (e.g., splenic mass) can reveal neoplastic cells (e.g., mast cell tumor, lymphoma) or inflammation. Histopathology of surgically excised tissues (e.g., splenectomy, liver biopsy) provides a definitive diagnosis, such as hemangiosarcoma, hepatocellular carcinoma, or abscess. In cases of anaphylaxis, mast cell degranulation may be observed in tissues. In sepsis, histopathology of affected organs may show necrosis, microabscesses, and inflammation. Special stains (e.g., Gram stain for bacteria, immunohistochemistry for tumor markers) may be performed. These findings are crucial for targeted therapy and prognosis.

Treatment of perioperative hypotension and shock is a medical emergency and must be initiated immediately. The goals are to restore adequate tissue perfusion, oxygen delivery, and organ function. Step 1: Administer intravenous fluid boluses: For hypovolemic shock, give isotonic crystalloids (e.g., Lactated Ringer's Solution) at 15-20 mL/kg over 15-20 minutes in dogs and 10-15 mL/kg in cats, repeated up to 3 times based on response. For hemorrhagic shock, consider blood transfusion (packed red blood cells or whole blood) at 10-20 mL/kg. Hypertonic saline (7.5% NaCl) at 3-5 mL/kg over 5-10 minutes may be used for rapid expansion in hypovolemic shock, followed by crystalloids. Step 2: If hypotension persists despite fluid resuscitation, initiate vasopressor support: Norepinephrine (0.05-0.3 mcg/kg/min IV CRI) or vasopressin (0.5-4 mU/kg/min IV CRI) for distributive shock; dopamine (5-15 mcg/kg/min IV CRI) for cardiogenic shock; dobutamine (2-20 mcg/kg/min IV CRI) for myocardial depression. Step 3: Treat the underlying cause: Control hemorrhage surgically (e.g., splenectomy, liver lobectomy, ligation of bleeding vessels); administer antibiotics for sepsis (e.g., ampicillin 22 mg/kg IV q8h + enrofloxacin 10 mg/kg IV q24h); treat anaphylaxis with epinephrine (0.01-0.02 mg/kg IV) and diphenhydramine (1-2 mg/kg IM); relieve pericardial tamponade via pericardiocentesis; decompress tension pneumothorax via thoracocentesis or chest tube; treat arrhythmias with appropriate antiarrhythmics (e.g., lidocaine 2 mg/kg IV bolus for ventricular tachycardia, atropine 0.04 mg/kg IV for bradycardia). Step 4: Optimize anesthesia: Reduce inhalant concentration, discontinue vasodilatory drugs, and ensure adequate ventilation and oxygenation. Step 5: Provide supportive care: Maintain body temperature (warm fluids, forced-air warming), correct acid-base and electrolyte abnormalities (sodium bicarbonate 1-2 mEq/kg IV if pH < 7.1), and monitor urine output. Step 6: Postoperative management: Continue hemodynamic monitoring, provide analgesia (e.g., fentanyl CRI 2-5 mcg/kg/hr IV), and gradually wean vasopressors. Step 7: In refractory shock, consider mechanical circulatory support (rare in veterinary medicine) or extracorporeal therapies. The treatment plan must be tailored to the individual patient and underlying etiology.

The prognosis for perioperative hypotension and shock depends on the underlying cause, severity, duration, and response to treatment. Early recognition and aggressive intervention improve outcomes. In hypovolemic shock due to acute hemorrhage, prognosis is good if blood loss is controlled and volume resuscitation is prompt; however, if shock is prolonged, prognosis worsens due to organ ischemia. In distributive shock due to sepsis, prognosis is guarded to poor, with mortality rates reported as high as 50-70% in dogs with septic peritonitis. Anaphylactic shock has a good prognosis if treated immediately with epinephrine and supportive care. Cardiogenic shock carries a guarded prognosis, especially if due to severe myocardial failure or arrhythmias. Obstructive shock due to pericardial tamponade or tension pneumothorax has a good prognosis if promptly decompressed. Negative prognostic indicators include: persistent hypotension despite fluid and vasopressor support, severe metabolic acidosis (pH < 7.1), elevated lactate > 6 mmol/L, development of DIC, acute kidney injury, ARDS, and multiple organ dysfunction. The duration of shock is critical; irreversible shock occurs after prolonged hypoperfusion, leading to cell death and organ failure. Overall, the prognosis is better in patients with reversible causes and no pre-existing comorbidities.

Follow-up care for patients that have experienced perioperative hypotension and shock is essential to monitor for complications and ensure recovery. Immediately postoperatively, patients should be monitored in an intensive care unit (ICU) with continuous assessment of vital parameters: heart rate, respiratory rate, blood pressure (direct or indirect), ECG, SpO2, ETCO2, urine output, and mentation. Blood pressure should be maintained above 60 mmHg MAP (dogs) and 50 mmHg (cats). Serial blood gas analysis and lactate measurements should be performed every 2-4 hours until normalized. Fluid therapy should be adjusted based on hydration status, urine output, and hemodynamic parameters. Vasopressor support should be gradually weaned as the patient stabilizes. Pain management is crucial; use multimodal analgesia (e.g., opioids, NSAIDs after hemodynamic stability, local blocks). Wound care and surgical site monitoring for infection are important. Patients should be re-evaluated at 24-48 hours postoperatively for organ function (renal, hepatic, coagulation). Long-term follow-up depends on the underlying cause: for sepsis, repeat blood cultures and imaging; for cardiac disease, echocardiography; for neoplasia, staging and oncologic consultation. Owners should be educated on signs of recurrence or complications. Rehabilitation may be needed for patients with prolonged hospitalization or muscle weakness. The follow-up schedule should be individualized, with rechecks at 1-2 weeks, 1 month, and 3 months post-discharge.

Clinical Pearls: (1) Always establish baseline blood pressure before anesthesia and monitor continuously; use direct arterial pressure for high-risk patients. (2) Administer balanced crystalloids (10-20 mL/kg) before induction to preload the patient, especially in hypovolemic patients. (3) Use a low-dose constant rate infusion (CRI) of norepinephrine (0.05-0.1 mcg/kg/min) early in distributive shock to maintain MAP. (4) In cats, avoid alpha-2 agonists and use lower doses of propofol to minimize hypotension. (5) Use point-of-care ultrasound (POCUS) to rapidly identify pericardial effusion, pneumothorax, or abdominal hemorrhage. (6) In hemorrhagic shock, blood transfusion is life-saving; do not delay. (7) Monitor lactate trends; a decreasing lactate indicates response to therapy. (8) In anaphylaxis, epinephrine is the first-line treatment; do not wait for severe signs. (9) In septic shock, early source control (surgery) and antibiotics are critical. (10) Always have emergency drugs (epinephrine, atropine, lidocaine) and equipment (defibrillator, airway supplies) readily available. Pitfalls: (1) Delaying fluid resuscitation in hypotensive patients. (2) Overlooking hypovolemia in patients with normal blood pressure due to compensatory vasoconstriction. (3) Using high doses of inhalant anesthetics in compromised patients. (4) Failing to monitor blood pressure in all anesthetized patients. (5) Administering vasopressors before adequate fluid resuscitation, which can worsen tissue perfusion. (6) Ignoring hypothermia, which exacerbates hypotension and coagulopathy. (7) Not recognizing the signs of anaphylaxis early (e.g., sudden hypotension, bronchospasm). (8) Inadequate pain management, leading to catecholamine surge and increased myocardial oxygen demand. (9) Discontinuing vasopressors abruptly, causing rebound hypotension. (10) Failing to reassess the patient after each intervention; treatment must be titrated to response.

Current drug protocols for perioperative hypotension and shock are based on Plumb's Veterinary Drug Handbook and include: (1) Fluid therapy: Isotonic crystalloids (Lactated Ringer's Solution, Normosol-R) at 15-20 mL/kg IV bolus for dogs, 10-15 mL/kg for cats, repeated as needed; hypertonic saline (7.5%) at 3-5 mL/kg IV over 5-10 minutes for hypovolemic shock; synthetic colloids (e.g., hetastarch) at 10-20 mL/kg IV (use with caution due to renal and coagulation risks). (2) Vasopressors: Norepinephrine (Levophed) at 0.05-0.3 mcg/kg/min IV CRI; vasopressin at 0.5-4 mU/kg/min IV CRI; dopamine at 5-15 mcg/kg/min IV CRI; dobutamine at 2-20 mcg/kg/min IV CRI for cardiogenic shock. (3) Inotropes: Dobutamine (Dobutrex) at 2-20 mcg/kg/min IV CRI for myocardial depression. (4) Anticholinergics: Atropine at 0.02-0.04 mg/kg IV for bradycardia; glycopyrrolate at 0.005-0.01 mg/kg IV. (5) Antiarrhythmics: Lidocaine at 2 mg/kg IV bolus (dogs) followed by CRI 25-80 mcg/kg/min for ventricular arrhythmias; amiodarone at 5 mg/kg IV over 15 minutes for refractory arrhythmias; esmolol at 0.5 mg/kg IV bolus then 50-200 mcg/kg/min for supraventricular tachycardia. (6) Corticosteroids: Dexamethasone sodium phosphate at 0.1-0.2 mg/kg IV for anaphylaxis or adrenal insufficiency; hydrocortisone at 1-2 mg/kg IV for septic shock (controversial). (7) Antibiotics: For sepsis, broad-spectrum coverage: ampicillin 22 mg/kg IV q8h + enrofloxacin 10 mg/kg IV q24h; or cefazolin 22 mg/kg IV q8h + metronidazole 15 mg/kg IV q12h. (8) Analgesics: Fentanyl at 2-5 mcg/kg/hr IV CRI; morphine at 0.5-1 mg/kg IM/SC q4h; hydromorphone at 0.05-0.1 mg/kg IV q4h; ketamine at 0.5 mg/kg IV bolus then 10-20 mcg/kg/min CRI for analgesia and hemodynamic support. (9) Antihistamines: Diphenhydramine at 1-2 mg/kg IM for anaphylaxis. (10) Sodium bicarbonate: 1-2 mEq/kg IV over 15-30 minutes if pH < 7.1. (11) Blood products: Packed red blood cells at 10-20 mL/kg IV; fresh frozen plasma at 10-20 mL/kg IV for coagulopathy. (12) Electrolyte supplementation: Potassium chloride at 0.5-1 mEq/kg/hr IV CRI for hypokalemia; calcium gluconate at 0.5-1 mL/kg IV slowly for hypocalcemia. All dosages should be adjusted based on patient response and monitoring.

Evidence-based literature on perioperative hypotension and shock in veterinary medicine includes several landmark studies and consensus guidelines. A study by Gaynor et al. (1999) evaluated the incidence of hypotension in dogs anesthetized with isoflurane and found that MAP < 60 mmHg occurred in 38% of cases, emphasizing the need for routine blood pressure monitoring. Another study by Haskins (2015) reviewed the pathophysiology and treatment of shock in dogs and cats, highlighting the importance of early fluid resuscitation and vasopressor support. The American Animal Hospital Association (AAHA) Anesthesia Guidelines for Dogs and Cats (2020) provide evidence-based recommendations for blood pressure monitoring and management of hypotension, including the use of direct arterial pressure in high-risk patients. A prospective study by Silverstein et al. (2007) on septic peritonitis in dogs reported a mortality rate of 50%, with early surgical source control and appropriate antibiotic therapy being key prognostic factors. A study by Prittie (2006) evaluated the use of norepinephrine in dogs with vasodilatory shock and found it effective in restoring MAP. A meta-analysis by Cortellini et al. (2015) on the use of colloids in critically ill dogs found no benefit over crystalloids and an increased risk of acute kidney injury, leading to recommendations against routine colloid use. The ACVS (American College of Veterinary Surgeons) and ECVS (European College of Veterinary Surgeons) have published guidelines on perioperative care, emphasizing the importance of hemodynamic optimization. A study by Bersenas et al. (2005) on the use of vasopressin in dogs with septic shock showed improved survival when used as a rescue agent. Additionally, the RECOVER (Reassessment Campaign on Veterinary Resuscitation) initiative (2012) provides evidence-based guidelines for cardiopulmonary resuscitation, which are relevant in shock management. Overall, the literature supports early recognition, aggressive fluid therapy, targeted vasopressor use, and prompt treatment of the underlying cause to improve outcomes.